Scientific Research News

MANHASSET, N.Y.--(BUSINESS WIRE)--Researchers at Northwell Health’s Feinstein Institutes for Medical Research found that obinutuzumab, a therapeutic antibody that depletes B cells and is approved for the treatment of B cell malignancies, benefitted patients with lupus nephritis, a severe complication of lupus that compromises kidney function. The study, which was led by Richard A. Furie, MD, professor in the Feinstein Institutes’ Institute of Molecular Medicine and The Marilyn and Barry Rubenst...

RUTHERFORD, Calif.--(BUSINESS WIRE)--One Mind is now actively accepting applications for the 2025 One Mind Rising Star Awards program. Since its founding, One Mind has supported the curiosity and drive of the most promising early career scientists, enabling stunning breakthroughs and launching their careers as leaders. In 2005, One Mind formalized this strategy, launching the Rising Star Awards program with the fundamental belief that investing in world-class early-career investigators pursuing...

OXFORD, England--(BUSINESS WIRE)--A new paper, released this week on bioRxiv, introduces hifiasm-ONT, a breakthrough genome assembly algorithm that enables partially phased, near telomere-to-telomere (T2T) assemblies1, using Oxford Nanopore Simplex reads and standard sample prep. Developed by Haoyu Cheng, Han Qu, Heng Li, and Peter Park, with support from Oxford Nanopore’s machine learning and applications teams, this major algorithmic innovation unlocks the length advantage of Oxford Nanopore’...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 12, 2025, at 2 pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France....

PRINCETON, N.J.--(BUSINESS WIRE)--U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications...

FRAMINGHAM, Mass. & ATHENS, Greece--(BUSINESS WIRE)--Ameresco SUNEL Energy SA, a joint venture between Ameresco, Inc., (NYSE: AMRC), a leading energy solutions provider dedicated to helping customers navigate the energy transition, and SUNEL Group, an international solar PV EPC contractor, today announced €303.4 million EPC Contracts for three solar parks located in the southwestern region of Romania. These 466 MWp solar projects represent a major milestone in Romania's journey towards enhancin...

TORRANCE, Calif.--(BUSINESS WIRE)--Reproductive Partners Medical Group (RPMG), a nationally recognized leader in fertility care and IVF innovation, is proud to announce the relocation of its Redondo Beach clinic to a brand-new, state-of-the-art facility in Torrance, California, beginning April 14th, 2025. After more than 30 years of providing comprehensive fertility care at its Redondo Beach location—the first IVF lab in the South Bay—RPMG is entering a new era of patient-centered fertility car...

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, introduced its artificial intelligence (AI) algorithm which accurately predicted revenue outcomes for over 90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%). Trinity’s latest white paper in its Industry Impact Series, titled Predicting Winners: AI-Powered Portfolio Management, explores the use...

LOS ANGELES--(BUSINESS WIRE)--Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, will present the latest cancer research at the AACR Annual Meeting 2025, which will take place April 25 to 30 in Chicago. City of Hope experts will present more than 74 chaired, plenary, educational, minisymposium, poster and other sessions...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by leveraging the two companies’ cutting-edge technologies and extensive expertise. SPERA PHARMA wil...